DATA PLANS
Download historical data for 20 million indicators using your browser.
Subscription Plans
|
Features
API GATEWAY
Direct access to our data from your apps using any programing language.
Features
|
Documentation
Already a user?
Login
Light Mode
Dark Mode
Calendar
News
Markets
Currencies
Stocks
Commodities
Bonds
Crypto
Earnings
Holidays
Indicators
Inflation Rate
Interest Rate
Unemployment Rate
GDP Growth
GDP per Capita
GDP Value
Current Account
Credit Rating
Wages Growth
Gold Reserves
Government Debt
Crude Oil Production
Gasoline Prices
Heatmap Table
More Indicators
Countries
United States
China
Japan
Canada
Australia
Brazil
Russia
India
Euro Area
United Kingdom
Germany
France
Italy
Spain
Switzerland
Singapore
More Countries
Forecasts
Countries
Indicators
Currencies
Stocks
Commodities
Bonds
Crypto
Regeneron Pharmaceuticals | REGN - Market Capitalization
Chart
Quotes
Financials
1Y
5Y
10Y
25Y
MAX
Chart
Column
Line
Area
Spline
Splinearea
Trend
Average(4)
Histogram
Variance
Mean
Maximum
Minimum
Compare
Export
API
Embed
Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.
Features
Questions?
Contact us
Already a Member?
Login
The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.
API Features
Documentation
Interested?
Click here to contact us
Please Paste this Code in your Website
width
height
Preview
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals reported $89.83B in Market Capitalization this March of 2023, considering the latest stock price and the number of outstanding shares.
Market Capitalization
Change
Date
AbbVie
ABBV:US
USD 281.15B
4.65B
Mar/2023
Agenus
AGEN:US
USD 505M
227M
Mar/2023
Agios Pharmaceuticals
AGIO:US
USD 1.28B
267M
Mar/2023
Alimera Sciences
ALIM:US
USD 15M
4M
Mar/2023
Alnylam Pharmaceuticals
ALNY:US
USD 24.83B
4.41B
Mar/2023
Amgen
AMGN:US
USD 129.1B
11.04B
Mar/2023
Astellas Pharma
4503:JP
JPY 3.41T
223.42B
Mar/2023
AstraZeneca
AZN:LN
USD 174.08B
252.77M
Mar/2023
Biogen
BIIB:US
USD 40.17B
294M
Mar/2023
BioMarin Pharmaceutical
BMRN:US
USD 18.24B
992M
Mar/2023
Bluebird Bio
BLUE:US
USD 338M
236M
Mar/2023
Bristol-Myers Squibb
BMY:US
USD 145.78B
7.2B
Mar/2023
Eli Lilly
LLY:US
USD 327.06B
20.56B
Mar/2023
Esperion Therapeutics
ESPR:US
USD 142M
317M
Mar/2023
Gilead Sciences
GILD:US
USD 103.55B
4.13B
Mar/2023
GlaxoSmithKline
GSK:LN
GBP 58.52B
341.4M
Mar/2023
Incyte Corp
INCY:US
USD 16.11B
1.76B
Mar/2023
Intercept Pharmaceuticals
ICPT:US
USD 560M
48M
Mar/2023
Ionis Pharmaceuticals
IONS:US
USD 5.11B
253M
Mar/2023
Iveric bio Inc.
OPHT:US
USD 3.34B
426M
Mar/2023
J&J
JNJ:US
USD 402.75B
59.1B
Mar/2023
Kyowa Hakko Kirin
4151:JP
JPY 1.56T
72.36B
Mar/2023
Merck & Co
MRK:US
USD 269.98B
11.32B
Mar/2023
Moderna Inc
MRNA:US
USD 59.23B
9.78B
Mar/2023
Neurocrine Biosciences
NBIX:US
USD 9.87B
1.61B
Mar/2023
Novartis
NOVN:VX
USD 190.76B
10.17B
Mar/2023
Novartis
NVS:US
USD 208.53B
8.83B
Mar/2023
Opthea Ltd
OPT:AU
AUD 425.04M
37.67M
Dec/2022
Pfizer
PFE:US
USD 230.29B
57.33B
Mar/2023
Puma Biotechnology
PBYI:US
USD 144M
50M
Mar/2023
Regeneron Pharmaceuticals
REGN:US
USD 89.83B
11.26B
Mar/2023
Roche Holding
ROG:VX
CHF 242.33B
20.77B
Dec/2022
Sanofi
SNY:US
USD 137B
15.13B
Mar/2023
Sarepta Therapeutics
SRPT:US
USD 12.84B
1.46B
Mar/2023
Seattle Genetics
SGEN:US
USD 37.89B
14.02B
Mar/2023
Teva Pharmaceutical Industries Ltd
TEVA:IT
USD 35.65B
710.71M
Mar/2023
Ultragenyx Pharmaceutical
RARE:US
USD 2.82B
432M
Mar/2023
United Therapeutics
UTHR:US
USD 10.44B
2.23B
Mar/2023
Vertex Pharmaceuticals
VRTX:US
USD 81.16B
7.03B
Mar/2023
Financials
Stock Price
Assets
Cash and Equivalent
Cost of Sales
Current Assets
Current Liabilities
Debt
EBIT
EBITDA
Employees
EPS Earnings Per Share
Equity Capital and Reserves
Gross Profit on Sales
Interest Expense on Debt
Interest Income
Loan Capital
Market Capitalization
Net Income
Operating Expenses
Operating Profit
Ordinary Share Capital
PE Price to Earnings
Pre-Tax Profit
Sales Revenues
Selling and Administration Expenses
Stock
Trade Creditors
Trade Debtors